Ruth Rappaport

2.7k total citations · 1 hit paper
44 papers, 2.1k citations indexed

About

Ruth Rappaport is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Ruth Rappaport has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 12 papers in Infectious Diseases and 8 papers in Molecular Biology. Recurrent topics in Ruth Rappaport's work include Respiratory viral infections research (18 papers), Influenza Virus Research Studies (15 papers) and Viral gastroenteritis research and epidemiology (8 papers). Ruth Rappaport is often cited by papers focused on Respiratory viral infections research (18 papers), Influenza Virus Research Studies (15 papers) and Viral gastroenteritis research and epidemiology (8 papers). Ruth Rappaport collaborates with scholars based in United States, Finland and Hong Kong. Ruth Rappaport's co-authors include George R. Dodge, John S. Tam, Bruce D. Forrest, William C. Gruber, Sheau‐Mei Cheng, Aizhong Hu, Andrew J. Dunning, María Rosario Capeding, Tawee Chotpitayasunondh and D. Michael Gill and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Ruth Rappaport

42 papers receiving 1.9k citations

Hit Papers

Prostaglandin E inhibits the production of human interleu... 1982 2026 1996 2011 1982 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prostaglandin E inhibits the production of human interleukin 2.
    1982 360 citations Ruth Rappaport, George R. Dodge The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Rappaport United States 24 1.1k 650 464 275 236 44 2.1k
J A Winkelstein United States 26 730 0.7× 306 0.5× 955 2.1× 307 1.1× 168 0.7× 61 2.1k
Yunwen Hu China 29 1.3k 1.2× 648 1.0× 727 1.6× 459 1.7× 242 1.0× 68 2.3k
Hartmut J. Ehrlich Austria 31 798 0.7× 699 1.1× 653 1.4× 485 1.8× 116 0.5× 113 2.9k
J. J. Alexander South Africa 21 631 0.6× 486 0.7× 248 0.5× 414 1.5× 274 1.2× 41 1.8k
Michael E. Wiebe United States 10 525 0.5× 466 0.7× 1.2k 2.5× 497 1.8× 77 0.3× 19 2.5k
Stephan Schaefer Germany 30 2.3k 2.1× 316 0.5× 181 0.4× 500 1.8× 79 0.3× 87 3.1k
Silvia Stockinger Austria 26 453 0.4× 559 0.9× 1.6k 3.5× 623 2.3× 121 0.5× 28 2.6k
Pia Hartmann Germany 26 651 0.6× 562 0.9× 417 0.9× 325 1.2× 30 0.1× 76 1.9k
Daniel Scott‐Algara France 31 903 0.8× 653 1.0× 1.8k 3.8× 485 1.8× 42 0.2× 100 3.1k
Jaana Pirhonen Finland 26 1.2k 1.1× 471 0.7× 2.4k 5.1× 924 3.4× 91 0.4× 32 3.8k

Countries citing papers authored by Ruth Rappaport

Since Specialization
Citations

This map shows the geographic impact of Ruth Rappaport's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Rappaport with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Rappaport more than expected).

Fields of papers citing papers by Ruth Rappaport

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Rappaport. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Rappaport. The network helps show where Ruth Rappaport may publish in the future.

Co-authorship network of co-authors of Ruth Rappaport

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Rappaport. A scholar is included among the top collaborators of Ruth Rappaport based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Rappaport. Ruth Rappaport is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Villiers, Pierre J.T. De, A. Duncan Steele, Ruth Rappaport, et al.. (2009). Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older. Vaccine. 28(1). 228–234. 69 indexed citations
3.
4.
Tam, John S., María Rosario Capeding, Lucy Chai See Lum, et al.. (2007). Efficacy and Safety of a Live Attenuated, Cold-Adapted Influenza Vaccine, Trivalent Against Culture-Confirmed Influenza in Young Children in Asia. The Pediatric Infectious Disease Journal. 26(7). 619–628. 134 indexed citations
5.
Quiroz, Jorge A., et al.. (2007). Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody. Biologicals. 35(3). 183–187. 10 indexed citations
6.
Vesikari, Timo, Aino Karvonen, Tiina Korhonen, et al.. (2006). A Randomized, Double-Blind Study of the Safety, Transmissibility and Phenotypic and Genotypic Stability of Cold-Adapted Influenza Virus Vaccine. The Pediatric Infectious Disease Journal. 25(7). 590–595. 83 indexed citations
7.
Vesikari, Timo, Douglas Fleming, Javier Arı́stegui, et al.. (2006). Safety, Efficacy, and Effectiveness of Cold-Adapted Influenza Vaccine-Trivalent Against Community-Acquired, Culture-Confirmed Influenza in Young Children Attending Day Care. PEDIATRICS. 118(6). 2298–2312. 127 indexed citations
8.
Li, Fenglan, et al.. (2006). Semiquantitative one-step RT-PCR for simultaneous identification of human influenza and respiratory syncytial viruses. Journal of Virological Methods. 139(1). 90–92. 7 indexed citations
9.
Zhao, Ping, et al.. (2006). Genetic and phylogenetic analysis of multi-continent human influenza A(H1N2) reassortant viruses isolated in 2001 through 2003. Virus Research. 122(1-2). 200–205. 13 indexed citations
10.
11.
Zhao, Ping, et al.. (2005). Molecular Evolution of Human Influenza A/H3N2 Virus in Asia and Europe from 2001 to 2003. Journal of Clinical Microbiology. 43(12). 6130–6132. 28 indexed citations
12.
Mendelman, Paul M., Ruth Rappaport, Iksung Cho, et al.. (2004). LIVE ATTENUATED INFLUENZA VACCINE INDUCES CROSS-REACTIVE ANTIBODY RESPONSES IN CHILDREN AGAINST AN A/FUJIAN/411/2002-LIKE H3N2 ANTIGENIC VARIANT STRAIN. The Pediatric Infectious Disease Journal. 23(11). 1053–1055. 41 indexed citations
13.
Cheng, Sheau‐Mei, Raija Vainionpää, Ping Zhao, et al.. (2004). Detection of influenza B in clinical specimens: comparison of high throughput RT-PCR and culture confirmation. Virus Research. 103(1-2). 85–90. 16 indexed citations
14.
Ward, Richard L., et al.. (1998). Shedding of rotavirus after administration of the tetravalent rhesus rotavirus vaccine. The Pediatric Infectious Disease Journal. 17(5). 386–390. 22 indexed citations
15.
Ward, Richard L., D R Knowlton, Edward T. Zito, et al.. (1997). Serologic Correlates of Immunity in a Tetravalent Reassortant Rotavirus Vaccine Trial. The Journal of Infectious Diseases. 176(3). 570–577. 61 indexed citations
16.
Jin, Qi, Robyn L. Ward, D R Knowlton, et al.. (1996). Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses. Archives of Virology. 141(11). 2057–2076. 75 indexed citations
17.
Hum, Wah-Tung, et al.. (1988). Disposition of a novel recombinant tissue plasminogen activator, 62–89 tpa, in mice. Thrombosis Research. 50(1). 33–41. 13 indexed citations
18.
Kalyan, Narender K., et al.. (1988). Structure-function analysis with tissue-type plasminogen activator. Effect of deletion of NH2-terminal domains on its biochemical and biological properties.. Journal of Biological Chemistry. 263(8). 3971–3978. 65 indexed citations
19.
Rappaport, Ruth & George R. Dodge. (1982). Prostaglandin E inhibits the production of human interleukin 2.. The Journal of Experimental Medicine. 155(3). 943–948. 360 indexed citations breakdown →
20.
Rappaport, Ruth, et al.. (1974). Development of a Purified Cholera Toxoid II. Preparation of a Stable, Antigenic Toxoid by Reaction of Purified Toxin with Glutaraldehyde. Infection and Immunity. 9(2). 304–317. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J A Winkelstein Breakdown of academic impact, for papers by Yunwen Hu Breakdown of academic impact, for papers by Hartmut J. Ehrlich Breakdown of academic impact, for papers by J. J. Alexander Breakdown of academic impact, for papers by Michael E. Wiebe Breakdown of academic impact, for papers by Stephan Schaefer Breakdown of academic impact, for papers by Silvia Stockinger Breakdown of academic impact, for papers by Pia Hartmann Breakdown of academic impact, for papers by Daniel Scott‐Algara Breakdown of academic impact, for papers by Jaana Pirhonen
Rankless by CCL
2026